Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology.
about
Susceptibility to Cryptococcal Meningoencephalitis Associated With Idiopathic CD4+ Lymphopenia and Secondary Germline or Acquired Defects.Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).Hypohidrotic ectodermal dysplasia and immunodeficiency with coincident NEMO and EDA mutations.Bid Promotes K63-Linked Polyubiquitination of Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6) and Sensitizes to Mutant SOD1-Induced Proinflammatory Signaling in Microglia.Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis.Inhibitory effects of parthenolide on the activity of NF-κB in multiple myeloma via targeting TRAF6.Disulfide-mediated stabilization of the IκB kinase binding domain of NF-κB essential modulator (NEMO).Functional Evaluation of an IKBKG Variant Suspected to Cause Immunodeficiency Without Ectodermal Dysplasia.NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II.Two-sided ubiquitin binding of NF-κB essential modulator (NEMO) zinc finger unveiled by a mutation associated with anhidrotic ectodermal dysplasia with immunodeficiency syndrome.Whole Exome Sequencing, Familial Genomic Triangulation, and Systems Biology Converge to Identify a Novel Nonsense Mutation in TAB2-encoded TGF-beta Activated Kinase 1 in a Child with Polyvalvular Syndrome.The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells.
P2860
Q33772403-E547F328-8360-4847-9393-4A24A13F9726Q34241279-FCF07769-C285-4BE1-A7B3-867ACC141DC0Q34696221-42DDDF8C-A80F-4E40-8440-DF663EFF25E8Q35927447-CECD8D56-0BDE-4D5F-909E-1E7D439B2E98Q36909735-2C34B456-F7FA-4BEF-896D-1AA40011C212Q38171457-0E002403-69F4-4B24-BC69-CE22CB87B07DQ38752770-FCF32950-4259-4CCA-BA61-EBBE78DB18DFQ38864359-374F2821-A075-4D5E-B48C-26B6C17CEEF6Q38940206-EDEC40B2-C23C-44B1-99E7-FEF46C1E897CQ41921141-617D513D-2161-4A06-8A53-5431868E6802Q42369047-1349F9A5-9D35-46BB-8965-463188472F6EQ42732317-04BE63A9-54E1-4F5B-8CE8-501BE3DD4D7EQ48081226-6BCA7966-3BF7-4DC8-89E0-E1AADDEFD0D7Q48137311-05020F96-FEEA-44DE-B8FB-5ED6AB6AD6DF
P2860
Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Identification of a new NEMO/T ...... ontinentia pigmenti pathology.
@en
Identification of a new NEMO/T ...... ontinentia pigmenti pathology.
@nl
type
label
Identification of a new NEMO/T ...... ontinentia pigmenti pathology.
@en
Identification of a new NEMO/T ...... ontinentia pigmenti pathology.
@nl
prefLabel
Identification of a new NEMO/T ...... ontinentia pigmenti pathology.
@en
Identification of a new NEMO/T ...... ontinentia pigmenti pathology.
@nl
P2093
P2860
P356
P1476
Identification of a new NEMO/T ...... ontinentia pigmenti pathology.
@en
P2093
Alessandra Pescatore
Elio Esposito
Fabrice Agou
Francesca Fusco
Gilles Courtois
Jérémie Gautheron
Matilde Valeria Ursini
Shoji Yamaoka
P2860
P304
P356
10.1093/HMG/DDQ222
P577
2010-06-07T00:00:00Z